Aarvee Engineering IPO

Incorporated in 2005, Aarvee Engineering Consultants Limited is a technology-driven, multi-sectoral, multi-disciplinary infrastructure consultancy company with a global presence. The company provides design and supervision services across the entire project lifecycle, including feasibility studies, detailed project reports (DPR), pre-bid services, detailed design, project management consultancy (PMC), supervision of operations and maintenance, third-party inspection, and lenders engineering services. Aarvee serves both public and private sector clients, including government entities such as NHAI, MoRTH, Dedicated Freight Corridor Corporation of India Limited, Chennai Metro Rail Limited, Indian Railways zones, and various state development corporations, as well as private clients like Tata Projects Limited, JSW Hydro Energy Limited, Greenko Energies Private Limited, and Megha Engineering & Infrastructures Limited. The company has executed over 2,750 projects globally across 20 countries in Asia, Africa, Australia, and Europe. It has undertaken 98 overseas projects in Fiscal 2025, 2024, and 2023, often in collaboration with local partners and funded by international and multilateral agencies. Prominent international clients include Abia State Rural Access and Agricultural Marketing Project (RAAMP), Administracao Nacional De Estrada (ANE), FIPAG, Bangladesh Railways, Bowen Rail Company Pty Ltd., BCI Minerals Limited, Hcomm Rail Ltd, Kenya National Highways Authority, and Tanzania National Roads Agency. Aarvee operates through 3 Indian subsidiaries, including Hyve Global Engineering Private Limited, and 2 international subsidiaries: Aarvee Engineering Consultants Pty. Ltd. in Australia and Aarvee Associates Limited in the UK. As of June 30, 2025, the company had 3,505 employees, of whom 2,623 (74.83%) possess engineering expertise.

Information on this page is for general awareness only and is not investment advice. Grey market premium (when shown) is unofficial and indicative. Always read the RHP/DRHP and consult a qualified adviser before investing.